With the small rise of pox news going on in the U.S., be it the second case of monkeypox this year , to smallpox vials found at a vaccine research facility in Pennsylvania, it brings to question as to whether or not health companies that have the capability to manufacture vaccines, treatments, and test kits against smallpox will be the new growth sector of...
Possible big move coming for this one?
With all the money flowing between random tickers this one could catch some steam just like how it pumped and dumped last time. If you want a speculative play here you go
over
32$ buy dated calls for QS!
Microsoft Plans $60 Billion Share-Buyback Program and raised its quarterly dividend to 62 cents a share from 56 cents a share.
Based on the news and the bullish characteristics of the chart, my price target is 325usd before a pullback.
Microsoft released its fourth-quarter results on July 27. The company's revenue rose 21% year over year to $46.2 billion, beating forecasts by $1.9 billion, and earnings rose 49% to $2.17 per share, beating expectations by $0.25. Commercial cloud revenue - which comes primarily from Microsoft 365 (formerly Office 365), LinkedIn, Dynamics CRM, and the Azure cloud...
I have linked the $QQQ Video below
watching Volume and price action we have found ourselves at a major stopping resistance. With QQQ at the top of a well respected channel and $MSFT struggling to stay up we could see a pullback in the weeks to come.
Bullish Momentum.
Invest in what you like.
I don't see any bearish signs.
- Share your opinion in the comments below and support the idea.
Thank you for the support.
We are in pivotal part of the market where investors or unsure and fear is aplenty. That being said I always trying to come at the market as a day trader and swing trader without being emotionally attached to a stock. I like certain stocks on fundamentals and will buy them again long term, but as a day trader I am only in search of weekly or monthly flings. Those...
The vax includes SM 102 a toxic flammable liquid causes cancer, toxicity to organs, and skin issues. Doesn’t make income and has no products that are profitable. Worth no more than $5.
We got a 13% move to the high of the day and we took an ABC back 4% and now volume is coming in again and I think we will see more action to come over the next two weeks as they prepare to release their delayed easrnings. Always wonder when a company delays earning why and the reason behind it. These guys are being sued by 3-5 different law firms for supposedly...
Hello everyone, here is the top-down analysis for MICROSOFT, feel free to request any pair/instrument or ask any questions in the comment section below.
Best of luck!
